A Cancer and Leukemia Group B phase II study of sunitinib malate in patients with previously treated metastatic pancreatic adenocarcinoma (CALGB 80603).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples